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ABSTRACT
Previous studies have shown that carrying the minor T allele of the IGF 
C-1245T polymorphism was associated with higher circulating IGF-I 
levels, greater muscle mass and improved power athletic performance. 
The aim of the present study was to assess the frequency distribution of 
another IGF-I single nucleotide polymorphism (SNP), the A/G rs7136446, 
among Israeli athletes. The IGF A/G rs7136446 polymorphism was deter-
mined in 185 short (n=72) and long-distance (n=113) runners, 94 short 
(n=44) and long-distance (n=50) swimmers, 54 weight-lifters and 111 
controls. There were no significant differences in GG carriers, previously 
described as associated with higher maximal force production, between 
the athletes and controls. The only statistical significant difference in GG 
carriers was found between the sprinters (24%) and weight-lifters (9%; 
p<0.05). Although a single polymorphism cannot determine an athlete’s 
ability to succeed or fail in sports, the present findings suggest a poten-
tial importance of IGF-I polymorphisms mainly to power sports and in 
particular to speed sport performance.
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INTRODUCTION
Directing children to focus in a single sport before adolescence is discour-
aged. Despite that, an increasing number of children do specialize in specific 
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sport at an early age, and even compete in “elite” level. Moreover, several 
Olympic sports initiate their selection processes in an attempt to identify 
future champions even before elementary school [13]. Therefore, it seems 
that one of the key factors for competitive sports success is identification of a 
sport event that best matches the athlete’s ability at a proper age [32]. Recent 
efforts to identify relevant genes for human athletic excellence are difficult, 
mainly because each gene makes only a small contribution to the overall 
heritability. However, genetic polymorphism has been suggested as an addi-
tional, sometimes very important, piece in the puzzle of sport selection. The 
idea that genetic hormonal polymorphism may also be used for prediction 
of sports excellence has emerged in recent years, and is only in its origins. 
It is now well established that changes in insulin-like growth factor-I 
(IGF-I) play a pivotal role in the muscle adaptation to exercise [1, 9, 11, 
14, 15, 25, 28]. Previous studies in pre and late pubertal girls have shown 
that both functional (i.e. maximal oxygen consumption – VO2max) and struc-
tural (i.e. thigh muscle volume determined by magnetic resonance images) 
indices of fitness were correlated with serum IGF-I levels [10, 12]. There-
fore, the majority of studies on hormonal genetic polymorphism and athletic 
success focused on the IGF-I system. Interestingly, very few studies exam-
ined the variation of IGF-I polymorphism in professional athletes. C-1245T 
(rs35767) is a genetic variation in the promoter region of the IGF-I gene. 
The minor allele T is associated with higher circulating IGF-I levels [7, 26, 
27]. The frequency of the IGF-I promoter polymorphism was significantly 
greater among athletes compared to non-active controls with a considerably 
higher sequence frequency among strength athletes compared to team-sport 
athletes [20]. Higher VO2max level was found among Polish athlete’s carriers 
of the i88 and i94 allele tandem repeats of the IGF gene polymorphism, 
while carriers of the i86 allele had lower VO2max levels [16]. Consistent with 
the previous results, we demonstrated a higher frequency of the T/T poly-
morphism among Israeli athletes compared to non-existence among controls 
[4]. While half of the T/T polymorphism carriers were endurance athletes 
and half power athletes, endurance T/T carriers were of national level, but 
the power athletes were top-level athletes (international and Olympic). 
This suggested that the IGF-I T/T polymorphism possible association with 
greater muscle mass is more important to power sport excellence. 
The aim of the present study was to assess the frequency distribution of 
another IGF-I single nucleotide polymorphism (SNP), the A/G, rs7136446, 
among Israeli athletes. It was previously demonstrated that GG homozy-
gotes of the IGF-I rs7136446 SNP showed higher maximal force production 
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compared with the other genotypes, and logistic regression analysis showed 
that presence of the A allele decreased the odds for higher maximal force 
production. Therefore, we hypothesized that the prevalence of the GG IGF-I 
rs7136446 SNP would be higher among the athletes and mainly among the 
power athletes.
MATERIALS AND METHODS
Participants
Two hundred and thirty-nine track and field athletes (182 males and 57 
females, age 17–55 years) and 94 swimmers (61 males and 33 females, age 
16–49 years) participated in the study. Track and field athletes were assigned 
to three main sub-groups according to their event speciality during their 
athletic career: 1) long-distance runners (major event: 5000 m to marathon 
run, n=113), 2) short-distance runners (100–200 m sprinters and jumpers, 
n=72), and 3) weight lifters (major event: Snatch, Clean and jerk, n=54). 
Swimmers were assigned to two groups according to their main swimming 
event during their swimming career: 1) long-distance swimmers (major 
event: 400–1500 m swim, n=50), and 2) short-distance swimmers (major 
event: 50–100 m swim, n=44). All athletes were ranked among the top all-
time Israeli results in their event and had competed at national and/or inter-
national level on a regular basis. The control group consisted of 113 (92 
males and 21 females, age 20–29 years) non-athletic healthy individuals who 
were not engaged in competitive sport. Characteristics of the athletes and 
controls are presented in Table 1.
Table 1. Athletes and controls’ data. 
Group n Main event M/F Top/
National 
level
Age (Mean±SD, 
range)
Endurance runners 113 5000m-marathon 92/21 48/65 32.4 ±9.5 (17–55)
Sprinters/Jumpers 72 100–200m, jumps 49/23 28/44 30.5 ±13.7 (17–71)
Weight lifters 54 Snatch, Clean & Jerk 41/13 34/20 28.7+9.4 (17–47)
Long distance 
swimmers
50 400–1500m 32/18 20/30 25.3 ±9.3 (16–48)
Short distance 
swimmers
44 50–100 m 29/15 10/34 23.1 ±7.6 (16–49)
Controls 111 – 77/34 – 26.4 ±5.8 (19–29)
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The study was approved by the Institutional Review Board of the Hillel Yaffe 
Medical Center, Hadera, Israel, according to the Declaration of Helsinki. 
Written informed consent was obtained from each participant before the 
commencement of the study.
Genotyping
Genomic DNA was extracted from peripheral EDTA treated anti-coagulated 
blood using a standard protocol, described elsewhere [24]. Briefly, Lyses 
buffer (5 mL) containing 100 mM of tris HCl, pH = 8.5 + 0.5 M of EDTA + 
10% SDS + 5 M of NaCl 40 mL added D.D.W. to 1000 mL was added to the 
white cell solution. Proteinase K (200 μg) was added to the solution. The 
tubes were incubated at 50°C in a shaker incubator for overnight for diges-
tion. After digestion, one volume of ethanol (–20°C) was added to the lysate 
and the samples were swirled until precipitation was completed (20–30 min, 
until it became completely transparent). The DNA was recovered by lifting 
the aggregated precipitate from the solution, using a disposable tip. Excess 
liquid was dabbed off and the DNA was dispersed in a pre-labelled eppen-
dorf tube. The DNA was washed in TE solution. Genotypes were deter-
mined using the TaqMan allelic discrimination assay. The Assay-by-Design 
service (http://www.thermofisher.com) was used to set up a TaqMan allelic 
discrimination assay for the IGF1 A/G (rs7136446). 
Primer sequences were forward: AATTGGTTACCTGCTACATTGA, 
reverse: G GAGTTAACGCATCTCCTTACTG. Probe sequences were 
for –174G/C forward: VIC- CGCGTAGTCGAGCG, reverse: FAM- 
CGCTCGCTGCCCTAAGTGCT. The PCR reaction mixture included 5 ng 
genomic DNA, 0.125 μl TaqMan assay (40*, ABI), 2.5 μl Master mix (ABI) 
and 2.375 μl water. PCR was performed in 96 well PCR plates in an ABI 7300 
PCR system (Applied Biosystems Inc., Foster City, CA, USA) and consisted 
of initial denaturation for 5 min at 95 °C, and 40 cycles with denaturation 
of 15 s at 95 °C and annealing and extension for 60s at 63 °C. Results were 
analyzed by the ABI TaqMan 7900HT using the sequence detection system 
2.22 software (Applied Biosystems Inc.).
Statistical analysis
The SPSS statistical package, version 20.0, was used to perform all statistical 
analyses (SPSS, Chicago, IL, USA). A χ2-test was applied to confirm that 
the observed genotype frequencies were within the Hardy-Weinberg equi-
librium and to compare allele and genotype frequencies between athletes 
and controls, as well as between athletes from different sports and between 
different competitive groups (e.g. short versus long-distance). If observed or 
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expected values included a cell with a value of 5, we used a Fisher’s exact test 
to compare allele and genotype frequencies.
RESULTS
The prevalence of the A/G IGF-I rs7136446 single nucleotide polymorphism 
among Israeli long and short distance runners and swimmers and among 
weight lifters is shown in Table 2 and Figure 1. Genotype subtype did not 
differ by age or sex. In addition, IGF-I A/G genotype distribution was in 
agreement with the Hardy–Weinberg equilibrium within all groups (p > 0.05). 
Table 2. The preval ence of the A/G IGF-I rs7136446 polymorphism among Israeli long and 
short distance runners and swimmers and among weight lifters.
Genotype frequencies Allele frequencies
n AA AG GG A – allele G – allele
N % N % N % N % N %
Control 111 45 41% 50 45% 16 14% 140 63% 82 37%
Endurance Runners
Top level 48 18 38% 23 48% 7 15% 59 61% 37 39%
National level 65 28 43% 26 40% 11 17% 82 63% 48 37%
Total 113 46 41% 49 43% 18 16% 141 62% 85 38%
Sprinters and Jumpers
Top level 28 9 32% 13 46% 6 21% 31 55% 25 45%
National level 44 15 34% 18 41% 11 25% 48 55% 40 45%
Total 72 24 33% 31 43% 17 24% 79 55% 65 45%
Weight Lifters
Top level 34 15 44% 15 44% 4 12% 45 66% 23 34%
National level 20 5 25% 14 70% 1 5% 24 60% 16 40%
Total 54 20 37% 29 54% 5 9% 69 64% 39 36%
Short distance swimmers
Top level 10 4 40% 5 50% 1 10% 13 65% 7 35%
National level 34 11 32% 18 53% 5 15% 40 59% 28 41%
Total 44 15 34% 23 52% 6 14% 53 60% 35 40%
Long distance swimmers
Top level 20 7 35% 12 60% 1 5% 26 65% 14 35%
National level 30 11 37% 11 37% 8 27% 33 55% 27 45%
Total 50 18 36% 23 46% 9 18% 59 59% 41 41%
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Figure 1. The prevalence of the A/G IGF-I rs7136446 polymorphism among national and 
top level Israeli long and short distance runners and swimmers and among weight lifters.
Note: 2(1) = 4.41, p = 0.036, for GG genotype frequency, sprinters vs. weight lifters.
The higher prevalence of IGF-I rs7136446 GG genotype was found among 
sprinters and jumpers (21%, 25%, and 24% for top-, national-level and total, 
respectively); while the lower GG genotype frequencies were found among 
weight lifters (12%, 5%, and 9% for top-, national-level and total, respec-
tively, p<0.05). 
IGF-I rs7136446 GG genotype frequencies among endurance runners, 
swimmers and controls vary between 10 to 18%, and were similar to the 
prevalence found among healthy Finnish males [17]. There were no signifi-
cant differences in GG genotype carriers between short and long-distance 
runners and controls, between short and long-distance swimmers and 
controls, and between weight-lifters and controls. Also, there was no differ-
ence in IGF-I rs7136446 GG genotype frequencies between top and national 
level for all groups.
DISCUSSION
We examined the prevalence of the A/G IGF-I rs7136446 polymorphism 
among Israeli long and short distance runners and swimmers and among 
weight lifters. In contrast to our hypothesis, there were no significant differ-
ences in GG carriers between athletes (runners – short and long-distance, 
swimmers – short and long-distance, and weight-lifters) and controls. 
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However, interestingly, the prevalence of GG carriers was significantly 
greater among sprinters compared to weight-lifters suggesting that carrying 
this polymorphism is beneficial mainly for speed rather than strength sport 
events. 
The effect of IGF-I polymorphism on muscle mass and fitness character-
istics has been studied mainly among the elderly because of the age-related 
decrease in muscle mass and strength [22, 30], and the consequent reduction 
in functional abilities, increased risk of falling and fractures [21, 29]. Since 
the IGF-I gene regulates muscle hypertrophy, several studies have focused 
on the relationship between IGF-I polymorphism, IGF-I levels, muscle 
mass, and physical ability. The majority of these studies have demonstrated 
a significant relationship between the IGF 1245T SNP and both baseline fat 
free mass (FFM) and FFM response to training in the elderly population [8, 
18, 19, 31].
Surprisingly, very few studies have examined variation in IGF-I poly-
morphism among professional athletes [20]. The frequency of the IGF-I 
promoter polymorphism was significantly greater among athletes (9.2%) 
compared to non-active controls (2.4%). Moreover, among the athletes, a 
substantially higher sequence frequency was found among strength (11%) 
compared to team-sport athletes (7.8%). We previously demonstrated [4] 
in a cohort of Israeli athletes a higher frequency of the IGF C1245T T/T 
polymorphism among athletes (4.8%), while none of the control participants 
carried that polymorphism. Interestingly, half of the T/T polymorphism 
carriers were endurance athletes and half were power athletes. However, 
despite the equal distribution among endurance and power athletes, one of 
the most striking finding of the study was that while the endurance athletes 
with the T/T polymorphism were of national level, the power athletes were 
elite-level athletes (international and Olympic). The results suggested that 
the IGF-I T/T polymorphism possible association with muscle mass increase 
is more important to power sport performance and excellence. The main 
contribution of the present study assessing the frequency of another poly-
morphism of the IGF-I gene (i.e. IGF-I rs7136446) is that carrying the GG 
genotype was significantly more frequent among sprinters compared to 
weight lifters. All together this may suggest that among power sports, IGF-I 
polymorphism is more important to speed rather than strength athletes. 
Previous studies have demonstrated other polymorphism frequency differ-
ences between speed oriented and strength oriented athletes [3]. 
It is very frequent in sports genetic research to combine athletes from 
different sports-types but with similar metabolic demands (e.g. endurance 
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athletes: long-distance running, swimming, cycling and triathlon; power 
athletes: sprinting, jumping and weight lifting). Interestingly, we did not find 
a higher frequency of the IGF-I rs7136446 GG polymorphism among swim-
mers. This is consistent with our previous reports demonstrating that in 
contrast to elite endurance and power track and field athletes, single nucleo-
tide polymorphisms of IGF-I and the IGF-I receptor and myostatin were not 
frequent among elite Israeli short- and long-distance swimmers [2, 4–6]. 
These results may indicate rather uniquely that the myostatin-IGF-I-IGF-I 
receptor growth factor system is less important for competitive swimming 
and elite swimming performance than for runners. The mechanism that 
may explain the different role of myostatin-IGF-I-IGF-I receptor growth 
factor system polymorphism in swimming compared to running perfor-
mance is currently unknown. One possible explanation is that excellence in 
swimming is largely affected by the swimming technique and by the swim-
mer’s size (particularly limb length) [23] which may, at least partially, mask 
metabolic and muscle mass differences between swimmers, enabling techni-
cally-skilled and/or tall swimmers to excel at all swimming distances, and 
particularly in the sprints. All together these results indicate that different 
sports disciplines (e.g. swimming and track and field) may have different 
genetic polymorphisms, despite seemingly similar metabolic characteristics. 
Thus, it should be acknowledged that combining different disciplines for 
sports genetic research purposes should not be done, or at least be done with 
extreme caution.  
In summary, although it is well recognized that a single polymorphism 
cannot determine an athlete’s ability to succeed or fail in sports, the findings 
suggest a potential importance of IGF-I polymorphisms mainly to power 
sports and in particular to speed sport performance in athletes. Whether a 
multi-potent athlete who wants to develop a competitive career and carries a 
beneficial IGF-I polymorphism should prefer track and field over swimming 
is currently hypothetical and speculative. Moreover, one should acknow-
ledge that while a favourable genetic predisposition is important, psycho-
logical and environmental aspects, including training equipment and facili-
ties, nutrition, familial support, and motivational issues, are also crucial for 
elite-level sports accomplishment.
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